Current location - Music Encyclopedia - Chinese History - Technical specification for clinical blood transfusion 2020 edition
Technical specification for clinical blood transfusion 2020 edition
specification for clinical transfusion technology

Whole blood and blood components should be carefully checked and accepted before storage. The acceptance contents include: transportation conditions, physical appearance, whether the blood bag is sealed and packaged, and whether the label is clear and complete (name of blood supply institution and its license number, name or barcode number of blood donor and blood type, blood type, volume, blood collection date, date and time of preparation of blood components, validity period and time, blood bag number/barcode, storage conditions), etc.

first

In order to regulate and guide the scientific and rational use of blood in medical institutions, this specification is formulated according to the People's Republic of China (PRC) Blood Donation Law and the Measures for the Administration of Clinical Blood Use in Medical Institutions (for Trial Implementation).

second

We must protect and rationally use blood resources, avoid waste and put an end to unnecessary blood transfusion.

essay

Clinicians and transfusion medical technicians should strictly grasp the indications of blood transfusion and correctly apply mature clinical blood transfusion techniques and blood protection techniques, including component blood transfusion and autologous blood transfusion.

Article 4

Hospitals above the second level should set up an independent blood transfusion department (blood bank), which is responsible for the technical guidance and implementation of clinical blood use, and ensure the implementation of scientific and reasonable blood use measures such as blood storage and blood matching.

Chapter II Application for Blood Transfusion

Article 5

To apply for blood transfusion, the attending physician shall fill in the Clinical Blood Transfusion Application Form one by one, and send it to the blood transfusion department (blood bank) for blood preparation before the scheduled blood transfusion date after being approved and signed by the attending physician.

Article 6

Before deciding on blood transfusion treatment, the attending physician should explain the adverse reactions of allogeneic blood transfusion and the possibility of blood-borne diseases to the patients or their families, obtain the consent of the patients or their families, and sign the consent form for blood transfusion treatment. The Consent of Blood Transfusion Treatment was included in the medical record. Emergency blood transfusion of patients without conscious signature of family members should be reported to the medical functional department or the competent leader for approval, filing and recording.

Article 7

Blood transfusion department (blood bank) is responsible for blood collection and storage before operation, and the attending physician is responsible for medical supervision during blood transfusion. Autotransfusion in the operating room, including acute normovolemic hemodilution, intraoperative autotransfusion and intraoperative controlled hypotension, is performed by anesthesiologists.

Article 8

Mutual blood donation by relatives and friends is mobilized by the attending physician and other patients' families, fill in the registration form in the blood transfusion department (blood bank), and donate blood free of charge at the blood collection point (room) approved by the blood station or the health administrative department. Blood stations shall conduct initial and re-examination of blood, and be responsible for allocating qualified blood.

Article 9

Patients with therapeutic blood component removal and plasma exchange. The application is made by the attending physician, the blood transfusion department (blood bank) or relevant departments participate in the formulation and implementation of the treatment plan, and the blood transfusion department (blood bank) and the attending physician are responsible for monitoring the treatment process of patients.

Article 10

For patients with Rh(D) negative and other rare blood group diseases, autologous blood transfusion, homologous blood transfusion or blood matching should be adopted.